VivoSim Labs (VIVS) Cash from Investing Activities (2010 - 2026)
VivoSim Labs (VIVS) posted Cash from Investing Activities of -$23000.0 for Q2 2026, down 124.47% on a QoQ basis from $94000.0 in Q1 2026.
Powered by 
Analysis
VivoSim Labs (VIVS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
VivoSim Labs has reported Cash from Investing Activities for 16 years, with the latest figure at -$23000.0 in Q2 2026.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$23000.0 in Q2 2026; TTM through Jun 2026 was $71000.0, a 99.21% decrease from a year earlier, with the FY2026 full-year figure at $94000.0, down 98.96% from the prior year.
- Cash from Investing Activities was -$23000.0 for Q2 2026 at VivoSim Labs, down from $94000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $10.0 million in Q4 2022, with the low at -$10.7 million in Q2 2022.
- Average Cash from Investing Activities over 5 years is $635214.3, with a median of $12500.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities sank 5411.86% in 2022, then surged 69138.46% in 2025.
- Over 5 years, Cash from Investing Activities stood at $10.0 million in 2022, then tumbled by 99.73% to $27000.0 in 2023, then plunged by 85.19% to $4000.0 in 2024, then jumped by 224925.0% to $9.0 million in 2025, then slumped by 100.26% to -$23000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$23000.0 (Q2 2026), $94000.0 (Q1 2026), and $9.0 million (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -381.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -23.89 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -108.34 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 28.10 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -7.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 11.09 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -55,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -55,941.69 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23,000.00 |
| Mar 31, 2026 | 94,000.00 |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 4,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 764,000.00 |
| Mar 31, 2023 | -162,000.00 |
| Dec 31, 2022 | 9.98 Mn |
| Sep 30, 2022 | -86,000.00 |
| Jun 30, 2022 | -10.69 Mn |
| Mar 31, 2022 | -53,000.00 |
| Dec 31, 2021 | -133,000.00 |
| Sep 30, 2021 | -29,000.00 |
| Jun 30, 2021 | -194,000.00 |
| Mar 31, 2021 | -111,000.00 |
| Dec 31, 2020 | -289,000.00 |
| Sep 30, 2020 | 5,000.00 |